Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases, Vascular

Explore clinical trials studying Skin Diseases, Vascular. Study availability and eligibility vary by location and protocol.

953 public trials 192 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases, Vascular trial results

Recruiting

Real-world Evaluation of the Effectiveness of Immunoglobulin-Histamine Complex, IHC (Histoglob) in Chronic Urticaria

NCT07680413

Conditions
Chronic Disease, Chronic Urticaria, Disease Attributes, +9 more
Locations
  • Vaishnavis skin Care & Cosmetic Ahmedabad, Gujarat, India
  • Matis Multispeciality Hospital Ahmedabad, Gujarat, India
  • L. G. Hospital Ahmedabad, Gujarat, India
  • Jupiter Hospital and Research Centre Vadodara, Gujarat, India
View all 40 locations
View Trial Details
Recruiting

A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)

NCT07266402

Conditions
Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +14 more
Locations
  • Cahaba Dermatology & Skin Health Center, LLC Birmingham, Alabama, United States
  • One of a Kind Clinical Research Center, LLC Scottsdale, Arizona, United States
  • Kern Research, Inc. Bakersfield, California, United States
  • One of a Kind Clinical Research Center Napa, California, United States
View all 73 locations
View Trial Details
Recruiting

A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO Trial

NCT05946564

Conditions
ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +10 more
Locations
  • CHU Amiens Amiens, France
  • CHU d'Angers Angers, France
  • CH de Boulogne sur Mer Boulogne-sur-Mer, France
  • CHU Brest - Hôpital de la Cavale Blanche Brest, France
View all 25 locations
View Trial Details
Recruiting

Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency

NCT07266805

Conditions
Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH), Acquired angioedema, Angioedema, +15 more
Locations
  • Study Site San Diego, California, United States
  • Study Site Walnut Creek, California, United States
  • Study Site St Louis, Missouri, United States
  • Study Site Hershey, Pennsylvania, United States
View all 32 locations
View Trial Details

Related conditions